Literature DB >> 24124662

Outcomes and prognostic factors in superficial spreading melanoma.

Michael E Egger1, Lindsay O Stepp, Glenda G Callender, Amy R Quillo, Robert C G Martin, Charles R Scoggins, Arnold J Stromberg, Kelly M McMasters.   

Abstract

BACKGROUND: Prognostic factors and risk factors for positive sentinel lymph node (SLN) biopsy results are important to identify in superficial spreading melanoma (SSM).
METHODS: A single-center database and a prospective clinical trial database were reviewed for all patients with diagnoses of SSM. Logistic regression, Kaplan-Meier survival analysis, and univariate and multivariate Cox models were used.
RESULTS: A total of 1,643 patients with SSM were identified. Independent risk factors for positive SLN biopsy results were Breslow thickness (BT) ≥2.0 mm, age <60 years, and presence of ulceration. BT ≥2.0 mm, ulceration, lymphovascular invasion, and positive SLN and positive non-SLN biopsy results were independent risk factors for worse disease-free survival. Independent overall survival risk factors included BT ≥2.0 mm, age ≥60 years, ulceration, nonextremity tumor location, lymphovascular invasion, and positive SLN biopsy results.
CONCLUSIONS: BT, ulceration, lymphovascular invasion, and SLN and non-SLN status are important risk factors for SSM.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymphovascular invasion; Melanoma histology; Melanoma prognosis; Nonsentinel lymph node melanoma; Sentinel lymph node biopsy melanoma; Superficial spreading melanoma

Mesh:

Year:  2013        PMID: 24124662     DOI: 10.1016/j.amjsurg.2013.09.003

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

Review 1.  Essential Components of Melanoma Histopathological Reporting: The Surgical Oncologist's Perspective.

Authors:  Vinka Nurdjaja; Masato Yozu; Jon A Mathy
Journal:  J Skin Cancer       Date:  2018-05-02

Review 2.  The prognostic significance of the clinical and histological parameters in primary cutaneous melanoma patients.

Authors:  Mihaela Antohe; Anastasia Coman; Gabriela Turcu; Roxana Ioana Nedelcu; Alice Brinzea; Mihaela Balaban; Andreea Moroianu; Lorena Manea; Ionela Hulea; Elena Balasescu; Sabina Andrada Zurac; Mirela Cioplea; Cristiana Popp; Luciana Nichita; Daniela Adriana Ion
Journal:  Med Pharm Rep       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.